Fountain’s packaged approach may appeal to someone who wants a clear path from an initial conversation to ongoing testosterone care. Before deciding whether it feels manageable, put the payment dates and expected appointments on the same calendar. The current offer is organized in weeks, not ordinary calendar months.
Our September 23, 2026 review examines the information Fountain publishes about that process. We have not enrolled as a patient or evaluated its clinical outcomes. The questions below are intended to help you understand what a personal care plan would involve before making a financial commitment.
KEEP IN MIND
A few things to remember.
- Keep the four-, 12-, or 48-week duration beside every price.
- Ask which exact medicine and pharmacy a personal plan would use.
- Plan testing, household precautions, and follow-up before committing.
Bring your reason for seeking care to the first conversation
Fountain describes a video assessment and laboratory evaluation before an appropriate treatment plan is chosen. That sequence matters more than selecting a product from the website. Tell the clinician what changed, how long it has been happening, and what other treatment or medical conditions might be relevant.
A testosterone diagnosis should not rest on age or a vague sense of feeling older. Endocrine Society guidance calls for symptoms or signs alongside reliably and consistently low levels, with repeat morning testing used for confirmation. Our first-conversation guide can help organize your history. Ask how the practice investigates another cause if testosterone results do not explain your symptoms.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · Endocrine Society: testosterone therapy clinical guidance
Put four weeks into an ordinary household budget
Fountain lists a $199 Starter plan covering four weeks, a $499 Standard plan covering 12 weeks, and a $1,799 Pro plan covering 48 weeks. These durations should stay attached to the prices. A four-week recurring payment will not always land on the same date each month, and the longest advertised period is shorter than 52 weeks.
Before choosing, request the next payment date and the total amount due now. Ask whether the commitment can change after a prescription adjustment and what happens if treatment is stopped. The cost planner can organize a confirmed quote, but it cannot decide what an unclear renewal or refund term means. Get that answer from the provider first.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing
Let the prescription identify the treatment
The advertised choices include injectable testosterone cypionate, a topical testosterone cream, and enclomiphene. These are not different packaging for one interchangeable medicine. In particular, enclomiphene should not be described as testosterone replacement in pill form. Ask what is proposed for you and what clinical reason supports it.
The prescription should identify the medication and pharmacy. If the preparation is compounded, ask why that is appropriate and how its status differs from an FDA-approved product. We did not establish a single pharmacy or formulation used for every Fountain patient. The medication and pharmacy questions provide a place to begin that discussion without assuming the website menu answers it.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · FDA: understanding the risks of compounded drugs
Find out where blood collection happens
Fountain presents care and laboratory testing within its package and describes local Labcorp collection as well as an upgraded home collection option. A home option may be convenient, but the upgrade should have its own written price and instructions. We did not verify a uniform fee that can be added to every plan.
Ask which tests are included before starting, which are repeated during treatment, and how additional testing is billed. If you already have results, ask whether they can be reviewed before ordering more. Our laboratory-plan guide explains how collection, results, and the clinician’s review fit together. The practical goal is knowing both where to go and who will explain what comes back.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · Endocrine Society: testosterone therapy clinical guidance
A cream needs a conversation about everyday contact
If the clinician suggests a topical product, describe ordinary contact with children, a partner, or someone you help care for. The medicine’s own directions should explain application and exposure precautions. Do not borrow the instructions for an unrelated gel because the product is also used on skin.
AndroGel’s approved label shows why secondary exposure deserves attention, but it does not establish the correct routine for a compounded cream. Read our household safety guide and ask the dispensing pharmacist to explain the actual product. If the routine would be difficult to follow consistently, say so before treatment is chosen rather than trying to improvise a solution later.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · DailyMed: AndroGel 1.62% prescribing information
Decide with the whole relationship in view
An ongoing plan should explain how to reach the medical team, when results are reviewed, and how a new symptom affects the next appointment or refill. Marketing descriptions of access and support are provider claims; we have not timed replies or tested those services. Ask what contact process applies outside a routine appointment.
Blood-pressure review and other patient-specific monitoring remain important, whatever route is prescribed. Fertility goals also deserve discussion before treatment. Our CoreAge Rx versus Fountain comparison separates a documented commercial offer from an unverified one. Fountain belongs on a shortlist when its actual schedule, prescription, clinical process, and payment terms fit your circumstances, not simply because the package sounds convenient.
Sources: Fountain: TRT options and four-week, 12-week, and 48-week billing · Endocrine Society: testosterone therapy clinical guidance · FDA: 2025 testosterone labeling and blood pressure changes
Sources you can check
Provider pages describe commercial offers. Medical references provide context. Checked September 23, 2026; prices and availability can change.
Educational information for adults, not a diagnosis or treatment plan. Discuss symptoms and treatment decisions with a licensed clinician. Do not change a prescription based on this article.